» Articles » PMID: 28740767

The Effect of the Timing of Radiotherapy on Clinical and Patient-Reported Outcomes After Latissimus Dorsi Breast Reconstruction: A 10-Year Study

Overview
Specialty General Surgery
Date 2017 Jul 26
PMID 28740767
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Breast reconstruction (BR) is considered to be adversely affected by radiotherapy (RT), particularly when an implant is used. The aim of this study was to compare clinical and patient-reported outcomes after expander-assisted latissimus dorsi breast reconstruction depending on the timing of RT.

Methods: Patients undergoing BR over a 10-year period (follow-up mean, 56 [14-134] months) were divided into 3 groups. Group 1, RT after mastectomy and BR, Group 2, RT before mastectomy and BR, and Group 3, RT after mastectomy but before BR. The primary endpoints were early and late surgical interventions. Validated questionnaires were circulated to all study patients and matched controls.

Results: Three hundred thirteen patients underwent 389 BRs. One hundred eighteen patients received RT, of which 65 had undergone expander-assisted latissimus dorsi breast reconstruction. Both use and timing of RT influenced clinical outcomes. Overall, use of RT resulted in a 3-fold increase in complications ( = 0.003). Postreconstruction RT resulted in more than double the number of complications compared with prereconstruction RT ( = 0.008) and delaying BR until after mastectomy and RT reduced complications to levels observed in control patients ( = nonsignificant). Complications were halved in patients undergoing autologous LD reconstruction ( = 0.0001). Patient-reported outcomes were similar for emotional well-being, satisfaction, and shoulder symptoms, although a nonsignificant increase in chronic breast symptoms was reported by the RT group.

Conclusion: The timing and type of LD reconstruction chosen by patients receiving RT has a significant impact on the risk of subsequent complications and unplanned interventions but has little impact on longer term patient well-being or satisfaction.

Citing Articles

Immediate Latissimus Dorsi and Prosthetic Reconstruction in the Setting of Postmastectomy Radiation: An Analysis of 376 Breast Reconstructions.

Chiasson K, Kumbla P, Restrepo R, Soto E, Cohn A Ann Plast Surg. 2020; 84(6S Suppl 5):S364-S368.

PMID: 32039998 PMC: 8612130. DOI: 10.1097/SAP.0000000000002279.


Patient-Reported Satisfaction Following Radiation of Implant-Based Breast Reconstruction.

Thiboutot E, Craighead P, Webb C, Temple-Oberle C Plast Surg (Oakv). 2019; 27(2):147-155.

PMID: 31106173 PMC: 6505354. DOI: 10.1177/2292550319826090.

References
1.
Cordeiro P, Pusic A, Disa J, McCormick B, VanZee K . Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg. 2004; 113(3):877-81. DOI: 10.1097/01.prs.0000105689.84930.e5. View

2.
Overgaard M, Jensen M, Overgaard J, Hansen P, Rose C, Andersson M . Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999; 353(9165):1641-8. DOI: 10.1016/S0140-6736(98)09201-0. View

3.
Overgaard M, Hansen P, Overgaard J, Rose C, Andersson M, Bach F . Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1998; 337(14):949-55. DOI: 10.1056/NEJM199710023371401. View

4.
Momoh A, Ahmed R, Kelley B, Aliu O, Kidwell K, Kozlow J . A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy. Ann Surg Oncol. 2013; 21(1):118-24. PMC: 4153348. DOI: 10.1245/s10434-013-3284-z. View

5.
Ragaz J, Olivotto I, Spinelli J, Phillips N, Jackson S, Wilson K . Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005; 97(2):116-26. DOI: 10.1093/jnci/djh297. View